Neuroscience, Cell Biology and Physiology Department, Wright State University, Dayton, OHIO 45435, United States.
Neuroscience, Cell Biology and Physiology Department, Wright State University, Dayton, Ohio 45435, United States.
Recent Pat Drug Deliv Formul. 2020;14(3):233-241. doi: 10.2174/1872211314999201117130123.
The purpose of this study was to determine if pharmacological treatment could increase progenitor cell proliferation in the Sub-ventricular Zone of aged rats. Previous work had shown that increasing progenitor cell proliferation in this region correlated well (R2=0.78; p= 0.0007) with functional recovery in a damaged corpus callosum (white matter tract), suggesting that progenitor cell proliferation results in oligodendrocytes in this region.
10 month old male and female Sprague Dawley rats were fed the drugs for 30 days in cookie dough, then immunocytochemistry was performed on coronal brain sections, using Ki67 labeling to determine progenitor cell proliferation.
Female rats showed low endogenous (control) progenitor cell proliferation, significantly different from male rats (P<0.0001), at this age. Ascorbic Acid (20 mg/kg, daily for 30 days) increased progenitor cell proliferation overall, but maintained the innate gender difference in stem cell proliferation (P=0.001). Prozac (5 mg/kg, daily for 30 days) increased progenitor cell proliferation for females but decreased stem cell proliferation for males, again showing a gender difference (P<0.0001). Simvastatin (1 mg/kg for 30 days) also increased progenitor cell proliferation in females and decreased progenitor cell proliferation in males, leading to a significant gender difference.
The three drug combinations (fluoxetine, simvastatin, and ascorbic acid, patent # 9,254,281) led to ~ 4 fold increase in progenitor cell proliferation in females, while male progenitor cell proliferation was highest with 50 mg/kg ascorbic acid. However, the ascorbic acid increase in proliferation appears to be only on the sides of the ventricles, which is not the region that normally gives rise to oligodendrocytes.
There are innate gender differences in progenitor cell proliferation at the Sub-Ventricular Zone at middle age in rats, possibly due to the loss of estrogen in females. We also see notable gender differences in progenitor cell proliferation in the Sub ventricular Zone in response to common drugs, such as fluoxetine, simvastatin and Vitamin C (ascorbic acid).
本研究旨在探讨药物治疗是否能增加老年大鼠侧脑室下区祖细胞的增殖。先前的研究表明,该区域祖细胞增殖的增加与受损胼胝体(白质束)的功能恢复密切相关(R2=0.78;p=0.0007),这表明该区域的祖细胞增殖导致少突胶质细胞的产生。
10 月龄雄性和雌性 Sprague Dawley 大鼠以曲奇面团的形式喂食药物 30 天,然后对冠状脑切片进行免疫细胞化学染色,使用 Ki67 标记来确定祖细胞的增殖情况。
在这个年龄段,雌性大鼠的内源性(对照)祖细胞增殖水平较低,与雄性大鼠有显著差异(P<0.0001)。抗坏血酸(20mg/kg,每日 30 天)总体上增加了祖细胞的增殖,但维持了固有性别间的干细胞增殖差异(P=0.001)。百忧解(5mg/kg,每日 30 天)增加了雌性大鼠祖细胞的增殖,但降低了雄性大鼠的祖细胞增殖,再次显示出性别差异(P<0.0001)。辛伐他汀(1mg/kg,30 天)也增加了雌性大鼠祖细胞的增殖,降低了雄性大鼠祖细胞的增殖,导致显著的性别差异。
三种药物组合(氟西汀、辛伐他汀和抗坏血酸,专利号 9,254,281)使雌性大鼠祖细胞的增殖增加了约 4 倍,而雄性大鼠的祖细胞增殖则以 50mg/kg 抗坏血酸为最高。然而,抗坏血酸增殖的增加似乎只发生在脑室的两侧,而不是通常产生少突胶质细胞的区域。
在中年大鼠的侧脑室下区,祖细胞的增殖存在固有性别差异,这可能是由于雌性大鼠雌激素的丧失。我们还观察到,在对常见药物(如氟西汀、辛伐他汀和维生素 C(抗坏血酸))的反应中,侧脑室下区的祖细胞增殖存在显著的性别差异。